[Clinical practice guidelines for hereditary cardiomyopathy].

Area of Science:

• Cardiology
• Genetics
• Molecular Biology

Background:

• Cardiomyopathies are heterogeneous heart muscle diseases.
• Genetic factors are common causes, leading to heart failure, arrhythmia, and sudden death.
• Primary types include hypertrophic, arrhythmogenic right ventricular, and dilated cardiomyopathies.

Purpose of the Study:

• To provide a guideline for managing genetic cardiomyopathies.
• To standardize clinical approaches based on current research and international guidelines.
• To summarize phenotype, diagnosis, and treatment strategies.

Main Methods:

• Genomic technology to identify common mutations.
• In vivo and in vitro studies to understand pathogenesis.
• Consensus of basic and clinical research, and international guidelines.

Main Results:

• Identification of common population mutations in cardiomyopathies.
• Insights into disease pathogenesis and potential therapeutic targets.
• Summary of diverse genetic cardiomyopathy types, phenotypes, and management.

Conclusions:

• Genomic insights are crucial for understanding cardiomyopathy pathogenesis.
• Standardized clinical management guidelines are needed.
• This guideline aims to improve patient care for genetic cardiomyopathies.